Solution structure of an oncogenic mutant of Cdc42Hs

被引:10
作者
Adams, PD [1 ]
Oswald, RE [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA
关键词
D O I
10.1021/bi051686g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cdc42Hs(F28L) is a single-point mutant of Cdc42Hs, a member of the Ras superfamily of GTP-binding proteins, that facilitates cellular transformation brought about by an increased rate of cycling between GTP and GDP [Lin, R., et al. (1997) Curr. Biol. 7, 794-797]. Dynamics studies of Cdc42Hs(F28L)-GDP have shown increased flexibility for several residues at the nucleotide-binding site [Adams, P. D., et al. (2004) Biochemistry 43, 9968-9977]. The solution structure of Cdc42Hs-GDP (wild type) has previously been determined by NMR spectroscopy [Feltham, J. L., et al. (1997) Biochemistry 36, 8755-8766]. Here, we describe the solution structure of Cdc42Hs(F28L)-GDP, which provides insight into the structural basis for the change in affinity for GDP. Heteronuclear NMR experiments were performed to assign resonances in the protein, and distance, hydrogen bonding, residual dipolar coupling, and dihedral angle constraints were used to calculate a set of low-energy structures using distance geometry and simulated annealing refinement protocols. The overall structure of Cdc42Hs(F28L)-GDP is very similar to that of wild-type Cdc42Hs, consisting of a centrally located six-stranded beta-sheet structure surrounding the C-terminal alpha-helix [Feltham, J. L., et al. (1997) Biochemistry 36, 8755-8766]. In addition, the same three regions in wild-type Cdc42Hs that show structural disorder (Switch 1, Switch 11, and the Insert region) are disordered in F28L as well. Although the structure of Cdc42Hs(F28L)-GDP is very similar to that of the wild type, interactions with the nucleotide and hydrogen bonding within the nucleotide binding site are altered, and the region surrounding L28 is substantially more disordered.
引用
收藏
页码:2577 / 2583
页数:7
相关论文
共 37 条
[1]   Backbone dynamics of an oncogenic mutant of Cdc42Hs shows increased flexibility at the nucleotide-binding site [J].
Adams, PD ;
Loh, AP ;
Oswald, RE .
BIOCHEMISTRY, 2004, 43 (31) :9968-9977
[2]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[3]   THE PROGRAM XEASY FOR COMPUTER-SUPPORTED NMR SPECTRAL-ANALYSIS OF BIOLOGICAL MACROMOLECULES [J].
BARTELS, C ;
XIA, TH ;
BILLETER, M ;
GUNTERT, P ;
WUTHRICH, K .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (01) :1-10
[4]   AMINO-ACID SUBSTITUTIONS AT CODON-13 OF THE N-RAS ONCOGENE IN HUMAN ACUTE MYELOID-LEUKEMIA [J].
BOS, JL ;
TOKSOZ, D ;
MARSHALL, CJ ;
VERLAANDEVRIES, M ;
VEENEMAN, GH ;
VANDEREB, AJ ;
VANBOOM, JH ;
JANSSEN, JWG ;
STEENVOORDEN, ACM .
NATURE, 1985, 315 (6022) :726-730
[5]  
BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0
[6]   From Ras signalling to ChoK inhibitors:: a further advance in anticancer drug design [J].
de Molina, AR ;
Rodríguez-González, A ;
Lacal, JC .
CANCER LETTERS, 2004, 206 (02) :137-148
[7]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[8]  
Delano WL., 2002, The PyMOL Molecular Graphics System
[9]   3-DIMENSIONAL STRUCTURE OF AN ONCOGENE PROTEIN - CATALYTIC DOMAIN OF HUMAN C-H-RAS P21 [J].
DEVOS, AM ;
TONG, L ;
MILBURN, MV ;
MATIAS, PM ;
JANCARIK, J ;
NOGUCHI, S ;
NISHIMURA, S ;
MIURA, K ;
OHTSUKA, E ;
KIM, SH .
SCIENCE, 1988, 239 (4842) :888-893
[10]   ANALYSIS OF RAS GENE-MUTATIONS IN ACUTE MYELOID-LEUKEMIA BY POLYMERASE CHAIN-REACTION AND OLIGONUCLEOTIDE PROBES [J].
FARR, CJ ;
SAIKI, RK ;
ERLICH, HA ;
MCCORMICK, F ;
MARSHALL, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1629-1633